TikTok creator weighs whether a peptide product holds up to its marketing
A short TikTok looks at one peptide product and its claims. The product and the verdict are not named in the listing.
Recap by typeshit. Video by TikTok on TikTok.
A short TikTok looks at one peptide product and its claims. The product and the verdict are not named in the listing.
Recap by typeshit. Video by TikTok on TikTok.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
A short post from the endocrinologist pushing back on headlines tying the eye condition to GLP-1 drugs, urging people to look at the data.
A brief post notes growing concern over reports of serious eye problems in people taking Ozempic and similar drugs, while research into the link continues.
Ashlee Rowe studies grasshopper mice that shrug off bark scorpion stings. OU has filed a patent on her redesigned peptides, which are not yet tested.
A short TikTok lists side effects tied to retatrutide, an experimental drug. There is little detail beyond the title.
Loading…